Kelvin Kow, DVM

   Assistant Professor
   Oncology
   Department of Small Animal Clinical Sciences


   Email:KowK@vetmed.ufl.edu


   PO Box 100000
   2015 SW 16th Ave
   Gainesville, FL 32608-0125
   (352) 392-2226 ext 5255
   Fax: (352) 392-7259

Education:

BS, Tulane University 1997

DVM, Louisiana State University 2003

Small Animal Medicine & Surgery Internship, Colorado State University 2004

Oncology Residency, Colorado State University 2007

MS, Colorado State University 2007

Diplomate, American College of Veterinary Internal Medicine (Oncology) 2007

Oncology Fellowship, Colorado State University 2008

 

Honors and Awards:

SCAVMA Outstanding Specialty Resident Award,Colorado State University College of Veterinary Medicine Awards Ceremony 2007. SCAVMA Outstanding Specialty Resident Award, Louisiana State University School of Veterinary Medicine, 2006. Edward Llyod Mitchell Memorial Award, 2003. Hershey Comeaux Memorial Award of Excellence, 2003. Pharmacia and Upjohn Small Animal Clinical Proficiency Award, 2003. American College of Veterinary radiology Award, 2003.

Research Interests:

-Telomerase as a cancer marker and therapeutic target

-Osteosarcoma

-Hemangiosarcoma

 

Selected Publications:

For Publications Extracted From Medline Click HERE

Thamm DH, Rose B, Kow K, Humbert M, Moussy A, Hermine O, Dubreuil P.

In-vitro investigation of Mastinib as a chemosensitizer in canine cancer. Proceedings of the 28th Annual Conference of the Veterinary Cancer Society. Seattle, WA, 2008

Kow K, Terry J, Grunerud K, Bailey S, Thamm D, Withrow S, Lana S.

Impact of telomerase status on canine osteosarcoma patients. Journal of Veterinary Internal Medicine, Nov-Dec; 22(6):1366-72. 2008 

Kow K, Thamm D, Terry J, Withrow S, Lana S, Bailey S.Impact of telomerase status on canine osteosarcoma patients. Proceedings of the AACR Special Conference in Cancer Research: The Role of Telomeres and Telomerase in Cancer Research. San Francisco, CA, 2007 

Kow K, Williams E, Bailey S, Withrow S, Lana S. Telomerase activity in canine osteosarcoma. Veterinary and Comparative Oncology. 4,3: 184-187, 2006

Kow K, Williams E, Bailey S, Withrow S, Lana S. Characterization of Telomeres and Telomerase in Canine Osteosarcoma. Proceedings of the 25th Annual Conference of the Veterinary Cancer Society. Huntington Beach, CA, 2005

Kow K, Bailey S, Withrow S, Lana S. Impact of Telomerase Status on Canine Osteosarcoma Patients. Proceedings of the 26th Annual Conference of the Veterinary Cancer Society. Pine Mountain GA, 2006

Aguilar R.F; Kow, K; McLachlan, J.M; Hammond, E.E; The zoo’s role in the study of endocrine disruptors. Proceedings of the American Association of Zoo Veterinarians 2003

Fox, J.E; Starcevic, M; Kow, K; Burow, M.E; McLachlan, JAEndocrine disrupters and flavonoid signaling. Nature 2001 413: 128-129 

Cheek, A.O., Chen, J., Kow, K.Y., McLachlan, J.A.Potential Mechanisms of Thyroid Disruption in Humans: Interaction of Organochlorine Compounds with Thyroid Receptor, Transthyretin, and Thyroid Binding Globulin. Environmental Health Perspective 1999, 107(4): 273-278 

Scripter, J.S, Ko, J., Kow, K.Y., Arimura, A.,Ide, C.F.Regulation by Interleukin-1b of Formation of a Line of Delimiting Astrocytes Following Prenatal Trauma to the Brain of the Mouse. Experimental Neurology 1997, 145: 329-41

  

Tran, D.Q, Kow, K.Y., McLachlan, J.A., and Arnold, S.F. The Inhibition of Chloro-S-triazine Derived Compounds is Dependent on Estradiol Concentration in Yeast. Biochemical and Biophysical Research Communications. 1996, 227(1): 140-6